Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques

被引:40
作者
He, Xuan [1 ]
Chandrashekar, Abishek [1 ]
Zahn, Roland [3 ]
Wegmann, Frank [3 ]
Yu, Jingyou [1 ]
Mercado, Noe B. [1 ]
McMahan, Katherine [1 ]
Martinot, Amanda J. [2 ]
Piedra-Mora, Cesar [2 ]
Beecy, Sidney [2 ]
Ducat, Sarah [2 ]
Chamanza, Ronnie [3 ]
Huber, Sietske Rosendahl [3 ]
van Heerden, Marjolein [3 ]
van der Fits, Leslie [3 ]
Borducchi, Erica N. [1 ]
Lifton, Michelle [1 ]
Liu, Jinyan [1 ]
Nampanya, Felix [1 ]
Patel, Shivani [1 ]
Peter, Lauren [1 ]
Tostanoski, Lisa H. [1 ]
Pessaint, Laurent [4 ]
Van Ry, Alex [4 ]
Finneyfrock, Brad [4 ]
Velasco, Jason [4 ]
Teow, Elyse [4 ]
Brown, Renita [4 ]
Cook, Anthony [4 ]
Andersen, Hanne [4 ]
Lewis, Mark G. [4 ]
Schuitemaker, Hanneke [3 ]
Barouch, Dan H. [1 ,5 ,6 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
[2] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA
[3] Janssen Vaccines & Prevent BV, Leiden, Netherlands
[4] Bioqual, Rockville, MD 20852 USA
[5] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[6] Massachusetts Consortium Pathogen Readiness, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
CELLS;
D O I
10.1016/j.cell.2021.05.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that a single immunization with an adenovirus serotype 26 (Ad26)-vector-based vaccine expressing an optimized SARS-CoV-2 spike (Ad26.COV2.S) protected rhesus macaques against SARS-CoV-2 challenge. To evaluate reduced doses of Ad26.COV2.S, 30 rhesus macaques were immunized once with 1 x 10(11), 5 x 10(10), 1.125 x 10(10), or 2 x 10(9) viral particles (vp) Ad26.COV2.S or sham and were challenged with SARS-CoV-2. Vaccine doses as low as 2 x 10(9) vp provided robust protection in bronchoalveolar lavage, whereas doses of 1.125 x 10(10) vp were required for protection in nasal swabs. Activated memory B cells and binding or neutralizing antibody titers following vaccination correlated with protective efficacy. At suboptimal vaccine doses, viral breakthrough was observed but did not show enhancement of disease, These data demonstrate that a single immunization with relatively low dose of Ad26.COV2.S effectively protected against SARS-CoV-2 challenge in rhesus macaques, although a higher vaccine dose may be required for protection in the upper respiratory tract.
引用
收藏
页码:3467 / +
页数:18
相关论文
共 50 条
[31]   SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike [J].
Guthmiller, Jenna J. ;
Stovicek, Olivia ;
Wang, Jiaolong ;
Changrob, Siriruk ;
Li, Lei ;
Halfmann, Peter ;
Zheng, Nai-Ying ;
Utset, Henry ;
Stamper, Christopher T. ;
Dugan, Haley L. ;
Miller, William D. ;
Huang, Min ;
Dai, Ya-Nan ;
Nelson, Christopher A. ;
Hall, Paige D. ;
Jansen, Maud ;
Shanmugarajah, Kumaran ;
Donington, Jessica S. ;
Krammer, Florian ;
Fremont, Daved H. ;
Joachimiak, Andrzej ;
Kawaoka, Yoshihiro ;
Tesic, Vera ;
Madariaga, Maria Lucia ;
Wilson, Patrick C. .
MBIO, 2021, 12 (01) :1-13
[32]   An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission [J].
Li, Weizhong ;
Wang, Tao ;
Rajendrakumar, Arunraj M. ;
Acharya, Gyanada ;
Miao, Zizhen ;
Varghese, Berin P. ;
Yu, Hailiang ;
Dhakal, Bibek ;
LeRoith, Tanya ;
Karunakaran, Athira ;
Tuo, Wenbin ;
Zhu, Xiaoping .
NATURE COMMUNICATIONS, 2023, 14 (01)
[33]   Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review [J].
Iqhrammullah, Muhammad ;
Rizki, Diva Rayyan ;
Purnama, Agnia ;
Duta, Teuku Fais ;
Harapan, Harapan ;
Idroes, Rinaldi ;
Ginting, Binawati .
SCIENTIA PHARMACEUTICA, 2023, 91 (01)
[34]   Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening [J].
Li, Daixi ;
Wang, Cheng ;
Wang, Shaobo ;
Mehmood, Aamir ;
Gu, Jiang ;
Cheng, Xin ;
Chen, Peiqin ;
Qiu, JingFei ;
Zhao, Jinghong ;
Wang, Junping ;
Wei, Dongqing .
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2022, 14 (01) :55-63
[35]   Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2 [J].
Faisca, Francisco ;
Correia, Vanessa ;
Petrovski, Zeljko ;
Branco, Luis C. ;
Rebelo-de-Andrade, Helena ;
Santos, Miguel M. .
PHARMACEUTICS, 2022, 14 (04)
[36]   Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection [J].
Che, Yinggang ;
Jiang, Dongbo ;
Zhang, Yong ;
Zhang, Junqi ;
Xu, Tianqi ;
Sun, Yuanjie ;
Fan, Jiangjiang ;
Wang, Jiawei ;
Chang, Ning ;
Wu, Yingtong ;
Yang, Shuya ;
Xu, Leidi ;
Ding, Jiaqi ;
Hu, Chenchen ;
Huang, Yinan ;
Zhang, Jian ;
Yang, Kun .
CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (12)
[37]   Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics [J].
Abd Elkodous, Mohamed ;
El-Sayyad, Gharieb S. ;
Abdel-Daim, Mohamed M. .
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2021, 28 (30) :40409-40415
[38]   EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2 [J].
Roshdy, Wael H. ;
Rashed, Helmy A. ;
Kandeil, Ahmed ;
Mostafa, Ahmed ;
Moatasim, Yassmin ;
Kutkat, Omnia ;
Abo Shama, Noura M. ;
Gomaa, Mokhtar R. ;
El-Sayed, Ibrahim H. ;
El Guindy, Nancy M. ;
Naguib, Amal ;
Kayali, Ghazi ;
Ali, Mohamed A. .
PLOS ONE, 2020, 15 (11)
[39]   Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? [J].
Chen, Guangbin ;
Lu, Hongzhou .
DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (03) :139-141
[40]   BCG immunization mitigates SARS-CoV-2 replication in macaques via monocyte efferocytosis and neutrophil recruitment in lungs [J].
Rahman, Mohammad Arif ;
Goldfarbmuren, Katherine C. ;
Sarkis, Sarkis ;
Bissa, Massimiliano ;
Gutowska, Anna ;
Schifanella, Luca ;
Moles, Ramona ;
Doster, Melvin N. ;
Andersen, Hanne ;
Jethmalani, Yogita ;
Serebryannyy, Leonid ;
Cardozo, Timothy ;
Lewis, Mark G. ;
Franchini, Genoveffa .
JCI INSIGHT, 2025, 10 (15)